Literature DB >> 1934593

Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency.

M E North1, G P Spickett, A D Webster, J Farrant.   

Abstract

Soluble CD8, soluble CD4, soluble CD25 (IL-2 receptor), beta 2-microglobulin and the cytokine tumour necrosis factor-alpha (TNF-alpha) were measured in sera from patients with common variable immunodeficiency (CVI). Levels of soluble CD8, soluble CD25 and beta 2-microglobulin but not of soluble CD4 and TNF-alpha were raised significantly above levels in normal sera. Sera from patients with X-linked agammaglobulinaemia, who are also antibody deficient, did not show this marked elevation. The raised levels of soluble CD8, soluble CD25 and beta 2-microglobulin in CVI, correlated with the extent of the defects in the B lymphocytes assessed in vitro, as well as with the clinical severity of the disease. The selective release of these molecules into sera may indicate that abnormal cellular activation occurs in most CVI patients. It is also possible that the raised levels of these soluble molecules play a part in the immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934593      PMCID: PMC1554116          DOI: 10.1111/j.1365-2249.1991.tb05805.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

Review 1.  Primary antibody deficiency in adults.

Authors:  G P Spickett; S A Misbah; H M Chapel
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

2.  A secreted form of the human lymphocyte cell surface molecule CD8 arises from alternative splicing.

Authors:  P Giblin; J A Ledbetter; P Kavathas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Role of retroviruses in acquired hypogammaglobulinaemia.

Authors:  G P Spickett; M Millrain; R Beattie; M North; J Griffiths; S Patterson; A D Webster
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

4.  In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis.

Authors:  H E Prince; S H Kleinman; V C Maino; A L Jackson
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

5.  Elevated serum interleukin-6 associated with a failure in B cell differentiation in common variable immunodeficiency.

Authors:  D C Adelman; T Matsuda; T Hirano; T Kishimoto; A Saxon
Journal:  J Allergy Clin Immunol       Date:  1990-10       Impact factor: 10.793

6.  Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation.

Authors:  D H Campen; D A Horwitz; F P Quismorio; G R Ehresmann; W J Martin
Journal:  Arthritis Rheum       Date:  1988-11

7.  Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.

Authors:  J A Symons; N C Wood; F S Di Giovine; G W Duff
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

8.  Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma.

Authors:  P R Greipp; J A Katzmann; W M O'Fallon; R A Kyle
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

9.  Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.

Authors:  M M Reddy; M Lange; M H Grieco
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

10.  Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.

Authors:  C H Pui; S H Ip; R K Dodge; S Carrabis; M Brown; W M Crist; C W Berard; P Kung; G V Dahl; S B Murphy
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

View more
  15 in total

Review 1.  Therapeutic strategies in common variable immunodeficiency.

Authors:  W A Carrock Sewell; Matthew Buckland; Stephen R A Jolles
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency.

Authors:  Timothy J Franxman; Laura E Howe; James R Baker
Journal:  J Clin Immunol       Date:  2014-07-27       Impact factor: 8.317

3.  Human cytomegalovirus infection is not increased in common variable immunodeficiency.

Authors:  C G Mullighan; S J Read; A G Bird; J B Kurtz; H M Chapel; K I Welsh
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

4.  Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features.

Authors:  P Aukrust; S S Frøland; F Müller
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

5.  Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets.

Authors:  M E North; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

6.  CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis.

Authors:  J Iglesias; N Matamoros; S Raga; J M Ferrer; J Mila
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

7.  Effect of 12,13-phorbol dibutyrate and ionomycin on defective B cells in common variable immunodeficiency.

Authors:  A Franz; A Bryant; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

8.  Duodenal intraepithelial gamma/delta T cells and soluble CD8, neopterin, and beta 2-microglobulin in serum of IgA-deficient subjects with or without IgG subclass deficiency.

Authors:  D E Nilssen; P Aukrust; S S Frøland; F Müller; O Fausa; T S Halstensen; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

9.  Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis.

Authors:  G Vitale; C Mocciaro; R Malta; G Gambino; A Spinelli; C Giordano; G Stassi; F Arcoleo; S Milano; E Cillari
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

10.  Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia.

Authors:  J Litzman; J Nechvatalova; J Xu; O Ticha; M Vlkova; Z Hel
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.